Related Experiment Video
Updated: Dec 26, 2025

Working with Human Tissues for Translational Cancer Research
Published on: November 26, 2015
New drugs and clinical trials rules 2019: Changes in responsibilities of the ethics committee
Neelu Singh1, Nivedita J Madkaikar2, Partha M Gokhale3
1Department of Clinical Research, Zydus Research Centre, Cadila Healthcare Limited, Ahmedabad, Gujarat, India.
Abstract:
The New drugs and Clinical trials rules 2019 (New rules) was introduced on 19th March 2019 by Government of India. New rules have set specific requirements for ethics committee (EC). The EC is required to follow requirements set as per New rules and to forward their report to Central Licensing Authority (CLA). This document is divided into different sections like definitions and applicable chapter & schedules for EC; changes related to registration of clinical studies and biomedical and health research; changes related to constitution, functions, proceedings, responsibility of EC for clinical trial; maintenance of records by EC; suspension and cancellation of registration of EC, post-trial access of drugs, changes and clarity related to academic clinical trials and role of ECs in compensation and medical management process.
More Related Videos
07:43Author Spotlight: Addressing Regulatory Gaps in Molecular Studies by Quantifying Viral Vectors in Complex Matrices
Published on: July 14, 2023
09:55Radiosynthesis, Quality Control, and Small Animal Positron Emission Tomography Imaging of 68Ga-Labelled Nano Molecules
Published on: October 4, 2024
Related Concept Videos
Clinical Trials: Overview
Drug Regulation
FDA Approved Drugs: Changes to Approved Drugs
Drug Control Governance: Regulatory Bodies and Their Impact
Clinical Trials
There are four phases in a clinical trial. A phase one...
Ethical Dilemmas II